Topical application of the rheumatoid arthritis drug Kineret (anakinra, Amgen) effectively treats the symptoms of dry eye disease, according to a study in the April 18 online edition of JAMA OphthalmoMore »
Patient enrollment has begun in the confirmatory Phase III clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain following cataract surgery.More »
Eleven Biotherapeutics recently presented data for EBI-005, the first interleukin-1 (IL-1) signaling inhibitor designed for topical ocular administration.More »
Phase II and III clinical data show that OMS302, which is being developed by Omeros Corporation, has a favorable impact on reducing the incidence of miosis during intraocular lens (IOL) replacement.More »
R-Tech Ueno is developing a recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) for the treatment of severe dry eye.More »
NEW YORK—A job as an optometrist or optician apparently is a good career path in 2013, according to a recent ranking by CareerCast.com, a career website that listed 200 jobs from best to worst.More »
NEW YORK—The Optical Business Barometer (OBB), a monthly gauge of general business attitudes among independent ECPs as surveyed by Jobson Research, rose to a 3.8 in March.More »
By studying intrinsically photosensitive retinal ganglion cells (ipRGCs) in mice, researchers at Johns Hopkins University found that the cells actually kill each other to seize more space and find theMore »
